Construction Business Review Conferences
The Novel CNS Biomarkers Summit Europe is the only European meeting dedicated exclusively to advancing fluid, imaging and digital biomarkers for CNS drug development. Join 60+ biomarker, translational medicine, neuroscience, precision medicine, bioanalytical, multi-omics, and clinical development leaders from leading organisations to explore how next-generation biomarkers are being discovered, validated and translated across Alzheimer's disease, Parkinson's disease, ALS, epilepsy, schizophrenia, MSA and other CNS indications
The PharmaLab Congress brings together laboratory professionals from Analytics, Bioanalytics and Microbiology for three days of knowledge sharing, discussion and networking.
Immunotherapies & Innovations for Infectious Diseases Congress (I4ID2026) , that will be held on October 22-23, 2026 at emlyon business school , Lyon, France. The purpose of this two-day congress is to foster interactions between pharmaceutical industries, research labs, service providers, technology developers, and clinicians, thereby contributing to the development of innovative strategies against infectious diseases in a multidisciplinary approach. I4ID2026 will build on the successes of the previous editions, the first one starting in 2017, that counted with the presence of more than 1800 participants from different countries representing over 500 organizations and 290 internationally renowned speakers exchanging on immunotherapy and new therapeutic approaches to fight infectious diseases.
ABIM is the premier global event for the biocontrol industry — the place where innovation is unveiled, new products are launched, market opportunities are shaped, and the latest research and regulatory developments are discussed. Every October, more than 2000 delegates from 65 countries gather at the Congress Center Basel in Switzerland. Representing over 800 companies and organisations worldwide, participants connect, exchange expertise, and gain valuable insights into the latest developments in the global biocontrol market.
BIOSPAIN 2026 will take place from 29 September to 1 October at the Bilbao Exhibition Centre (BEC), bringing together the global biotechnology community under the claim “Bioinnovation that clicks.” Organized by AseBio in collaboration with the Provincial Council of Bizkaia, the Basque Government and the Basque Health Cluster, the event reinforces its role as Spain’s flagship biotech congress and one of Europe’s leading life sciences gatherings. For the first time in its history, BIOSPAIN becomes an annual event, reflecting the sector’s growing momentum and international demand. The 2025 edition in Barcelona welcomed more than 2,400 attendees from 35 countries, confirming BIOSPAIN as a premier platform for business development, investment and strategic networking.
The Bioproduction Congress is the annual event of the biopharmaceutical production sector where stakeholders from Europe gather together to showcase and exchange the latest innovations in bioprocessing. This dynamic event promotes exchanges on the future of biomanufacturing, addresses the current challenges and showcases the new breakthrough solutions. This event will bring together experts from companies (big pharmas, SME and Startups) and laboratories developing therapeutic candidates as well as leading bioproduction professionals to accelerate therapeutics drugs such as mAbs, vaccines, cell therapy and novel products into commercial manufacturing.
Life science organisations are under mounting pressure to prove the value of patient engagement in hard numbers. Regulators demand transparency in reporting, executives expect clear ROI before committing resources, and patients want visible proof their voices are driving decisions, accelerating timelines, and improving outcomes. Yet despite years of progress, a unified, credible framework for measuring impact still doesn’t exist - leaving engagement efforts vulnerable to being dismissed as well-intentioned but non-strategic.
The Festival of Biologics Basel is Europe’s largest biologics event, covering the start-to-finish of the industry in antibody therapies, cell and gene therapies, immunotherapies and biosimilars. Designed for industry experts in pharma and biotech, start-ups, academics, regulators and investors, the Festival of Biologics is the meeting place for the large molecule therapy ecosystem, bringing together 3000+ attendees. Join 350 world class speakers in exploring the latest research in early stage discovery, modality engineering, translational medicine, clinical trials, manufacturing, commercialisation and fill/finish operations across key therapy and disease areas.
The Evolution Summit is an invitation-only, premium forum bringing leading clinical research executives and innovative solution providers. The summit’s content is aligned with key clinical R&D challenges and interests, relevant market developments, and practical and progressive ideas and strategies adopted by successful pioneers.
Life Sciences Baltics aims to tailor the event experience to each participant, ensuring the most relevant and impactful role for everyone. As the leading life sciences forum in the region, it serves as a global hub for top-tier biotechnology, pharmaceutical, medical device, and healthcare experts. The event is designed to maximize networking opportunities, fostering connections and collaborations that drive innovation and growth in the life sciences sector.
